Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Clinical trial NCT02393417 · COMPLETED
Trial details
- NCT number
- NCT02393417
- Sponsor
- Nielsen BioSciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2018-01-01
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.